Evidence map›Paper›PMID 32723565›Full record

ReviewAdvances in cancer research2020

Ca

Scott Gross, Pranava Mallu, Hinal Joshi, Bryant Schultz, Christina Go, Jonathan Soboloff

Open access · greenAbstract readReview
In one paragraph

Review in Advances in cancer research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
6.7field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Purinergic CaCancers · 2024
    Article
  7. Purinergic CabioRxiv : the preprint server for biology · 2024
    Article
  8. Article
  9. Review
  10. Multifaceted control of T cell differentiation by STIM1.Trends in biochemical sciences · 2023
    Review
  11. Review
  12. Review
  13. Review
  14. Review
  15. Suppression of CaThe EMBO journal · 2022
    Article
  16. Review
  17. The Important Role of Ion Transport System in Cervical Cancer.International journal of molecular sciences · 2021
    Review
  18. Repurposing of Anticancer Stem Cell Drugs in Brain Tumors.The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society · 2021
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Scott GrossFels Institute for Cancer Research and Molecular Biology, Lewis Katz School of Medicine at Temple University, Philadelphia, PA, United States.
Pranava MalluFels Institute for Cancer Research and Molecular Biology, Lewis Katz School of Medicine at Temple University, Philadelphia, PA, United States.
Hinal JoshiFels Institute for Cancer Research and Molecular Biology, Lewis Katz School of Medicine at Temple University, Philadelphia, PA, United States.
Bryant SchultzFels Institute for Cancer Research and Molecular Biology, Lewis Katz School of Medicine at Temple University, Philadelphia, PA, United States.
Christina GoFels Institute for Cancer Research and Molecular Biology, Lewis Katz School of Medicine at Temple University, Philadelphia, PA, United States.
Jonathan SoboloffFels Institute for Cancer Research and Molecular Biology, Lewis Katz School of Medicine at Temple University, Philadelphia, PA, United States; Department of Medical Genetics & Molecular Biochemistry, Lewis Katz School of Medicine at Temple University, Philadelphia, PA, United States. Electronic address: soboloff@temple.edu.
Temple University · US

Funding

Defining STIM1 function at the Immunological SynapseR01AI152506 · NIAID · TEMPLE UNIV OF THE COMMONWEALTH · PI SOBOLOFF, JONATHAN A · 2020 to 2024
$2.0M
EGR-mediated STIM1-PMCA expression and function in T cell subsetsR01GM117907 · NIGMS · TEMPLE UNIV OF THE COMMONWEALTH · PI SOBOLOFF, JONATHAN A · 2016 to 2019
$1.6M
NIAID NIH HHS R01 AI152506NIGMS NIH HHS R01 GM117907
6 · The paper itself

Abstract

Ca

Indexed as

AnimalsAntineoplastic AgentsCalciumCalcium ChannelsCell MembraneHumansMolecular Targeted TherapyNeoplasmsAntineoplastic AgentsCalciumCalcium ChannelsCalciumCancer progressionMetastasisSTIM1

Identifiers

PMID32723565
PMCPMC7412871
OpenAlexW3041281170

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.